The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGamma Communications Regulatory News (GAMA)

Share Price Information for Gamma Communications (GAMA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,342.00
Bid: 1,344.00
Ask: 1,350.00
Change: 0.00 (0.00%)
Spread: 6.00 (0.446%)
Open: 1,354.00
High: 1,360.00
Low: 1,342.00
Prev. Close: 1,342.00
GAMA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

H1 Trading Update

2 Aug 2022 07:00

RNS Number : 5294U
Gamma Communications PLC
02 August 2022
 

Gamma Communications plcH1 trading update

Strong first half performance, continued cash generation and positive business momentum

Gamma Communications plc ("Gamma" or the "Group"), a leading provider of Unified Communications as a Service ("UCaaS") to the business markets in the UK, Germany, Spain, and the Netherlands, is pleased to announce a trading update for the six months ended 30 June 2022. This update confirms the statements made at the time of the AGM on 19 May 2022.

Group overview

We are pleased to report that the Group performed well through the first six months of the year with strong year on year adjusted EBITDA growth.

In both the UK and Europe our resilient recurring revenue model, combined with selected price increases and strict cost discipline, has helped mitigate inflationary pressures, ensuring that the Group has good momentum going into the second half of the year. The Group continues to proactively manage its supply chain; given the well-publicised delays in the availability of various telco/networking hardware devices we deliberately built the UK Indirect Business inventory to over twice the levels we held pre-COVID.

United Kingdom

We have seen healthy momentum in the Indirect Business which remains on track to meet our targeted 8% growth in Gross Profit for FY 2022. There has been good sales traction on key new products such as Horizon Contact.

The Direct Business has seen a number of significant MS Teams user contract wins, including the Home Office and DWP in the public sector. A strong contracted pipeline, significantly ahead when compared to this time last year, across the Direct channel gives comfort on the sizeable growth we expect for the full year. Revenue growth will approach 10% (2022 against 2021). 

Overheads across the UK were within expectations during the first half and inflationary increases will continue to be challenged and tightly managed.  

Europe: Germany, Netherlands and Spain

Growth in UCaaS supported a good first half German business financial performance which counterbalanced some headwinds in our smaller Spanish business. Microsoft Teams Operator Connect was launched in the Netherlands and is planned to roll out in both Germany and Spain. We will also launch our contact centre product in Spain in the second half of the year.

Product development

The Group has continued to make progress on the expansion of the capabilities it offers to its customers, across all channels and countries, leveraging its growing in-house software development capability and the range of strategic partnerships it has developed.

Cash

Gamma's balance sheet remains strong, with significant cash generation from its trading activities. Closing net cash at the half year was approximately £72.6m compared to £49.5m at the end of the previous year. This is after paying £1.7m of contingent consideration on acquisitions and making early supplier payments to receive attractive prompt payer discounts. 

 

 

 

Outlook

The Board remains positive about the prospects for Gamma. In line with the statement made at the time of the AGM, management expects adjusted EBITDA and adjusted EPS for the year ending 31 December 2022 to be in the upper half of the range of market forecasts.*

The Board will announce results for the half year ended 30 June 2022 on Tuesday 6 September 2022.

Andrew Belshaw, Interim Chief Executive, commented on the results:

"I'm very pleased to report on a strong first half performance. Gamma is leveraging the full breadth of its market-leading product set both through the channel and direct across all of our markets.

Although not immune from the macro-economic challenges ahead, our recurring revenue model, strong cash generation and healthy balance sheet enables us to continue to invest in the undoubted market opportunity. Churn and bad debt remains at low levels and these results demonstrate the resilience of the customer base and the importance they attach to Gamma's products and services.

We look forward to continuing this momentum into the second half."

 

* Note: Company compiled range is based on known sell side analyst estimates. The ranges are Adjusted EBITDA £102.3m - £106.8m and Adjusted EPS 67.1 pence - 74.6 pence.

 

Gamma Communications plc

Andrew Belshaw, Chief Executive Officer

Bill Castell, Chief Financial Officer

Tel: +44 (0) 333 006 5972

Tulchan Communications LLP

James Macey White / Matt Low

Tel: +44 (0) 207 353 4200

 

Investec Bank plc (NOMAD & Broker)

Tel: +44 (0) 207 597 5970

Patrick Robb / Virginia Bull

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKZGGRRMKGZZM
Date   Source Headline
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 20247:00 amRNSTransaction in Own Shares
1st May 202412:19 pmRNSTotal Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20245:21 pmRNSDirector/PDMR Shareholding
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSHolding(s) in Company
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 202411:09 amRNSHolding(s) in Company
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20241:57 pmRNSDirector/PDMR Shareholding
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20243:19 pmRNSPublication of Notice of AGM
12th Apr 20243:05 pmRNSDirector/PDMR Shareholding
12th Apr 20243:00 pmRNSDirector/PDMR Shareholding
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20249:36 amRNSTransaction in Own Shares
3rd Apr 20247:55 amRNSTransaction in Own Shares
2nd Apr 20246:00 pmRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:02 amRNSShare buyback programme
25th Mar 20247:01 amRNSFinal Results
25th Mar 20247:00 amRNSBoard Change and Committee Composition
22nd Mar 20245:20 pmRNSHolding(s) in Company
14th Mar 20247:30 amRNSDirector/PDMR Shareholding
1st Mar 20242:31 pmRNSTotal Voting Rights
14th Feb 20248:38 amRNSDirector/PDMR Shareholding
13th Feb 20248:00 amRNSSite visit for investors
1st Feb 20241:49 pmRNSTotal Voting Rights
17th Jan 20243:51 pmRNSHolding(s) in Company
16th Jan 20247:00 amRNSScheduled Trading Update
15th Jan 20244:46 pmRNSDirector/PDMR Shareholding
2nd Jan 202410:24 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.